4//SEC Filing
Arix Bioscience plc 4
Accession 0000899243-19-029473
CIK 0001708493other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 7:20 PM ET
Size
11.5 KB
Accession
0000899243-19-029473
Insider Transaction Report
Form 4
Arix Bioscience plc
10% Owner
Transactions
- Sale
Common stock
2019-12-16$17.02/sh−13,080$222,680→ 2,584,835 total(indirect: See Footnote) - Sale
Common stock
2019-12-17$16.83/sh−12,476$209,969→ 2,572,359 total(indirect: See Footnote) - Sale
Common stock
2019-12-13$17.21/sh−11,002$189,341→ 2,597,915 total(indirect: See Footnote)
Arix Bioscience Holdings Ltd
10% Owner
Transactions
- Sale
Common stock
2019-12-13$17.21/sh−11,002$189,341→ 2,597,915 total(indirect: See Footnote) - Sale
Common stock
2019-12-16$17.02/sh−13,080$222,680→ 2,584,835 total(indirect: See Footnote) - Sale
Common stock
2019-12-17$16.83/sh−12,476$209,969→ 2,572,359 total(indirect: See Footnote)
Footnotes (4)
- [F1]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.68 per share, inclusive. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission (the "SEC"), the Issuer, or a security holder of the Issuer.
- [F2]These shares are owned directly by Arix Bioscience Holdings Limited, which is a wholly owned subsidiary of Arix Bioscience Plc. Arix Bioscience Plc is an indirect beneficial owner of the reported securities and disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
- [F3]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.28 per share, inclusive. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.
- [F4]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $16.80 to $17.00 per share, inclusive. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001700449
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 7:20 PM ET
- Size
- 11.5 KB